Mark G. Currie
InvestorVenture Partner at Iaso Ventures · Board director at Sea Pharmaceuticals
Boston, Massachusetts, United States
About
Biopharma leader and pharmacologist, former President and CSO and scientific founder of Cyclerion Therapeutics and R&D leader at Ironwood. Primary inventor of linaclotide (Linzess), with numerous board and advisory roles.
Board director at Sea Pharmaceuticals
Intro paths
→
In turn, Mark can intro founders to Sea Pharmaceuticals's investors below.
Sea Pharmaceuticals's investors · 1
Co-founders at Sea Pharmaceuticals
EO
Eric OlsonManager
BC
Benjamin CravattManager
Experience
- Prudentia SciencesChair SABcurrent2025 — presentGreater Boston
- Scaffold TherapeuticsChair SABcurrent2025 — presentBoston, Massachusetts, United States
- Iaso VenturesVenture Partnercurrent2024 — presentGreater Boston
- Antag TherapeuticsBoard Membercurrent2023 — presentCopenhagen, Capital Region of Denmark, Denmark
- Ironwood PharmaceuticalsDirector Board Of Directorscurrent2019 — present
- Ironwood PharmaceuticalsSenior Vice President2008 — 2019
- Sea PharmaceuticalsMember Board Of Directorscurrent2021 — present
- CyclerionChair of Scientific Advisory Board2021 — 2025
- CyclerionPresident2019 — 2021
- Science ExchangeDirector Board Of Directors2020 — 2025Palo Alto, California, United States
- MicrobiaChief Science Officer2002 — 2008Greater Boston Area
- Sepracor IncVice President of Discovery1999 — 2002Greater Boston Area
- SearleSenior Director Discovery Pharmacology1990 — 1999Greater St. Louis Area
Deals · 1
Sea PharmaceuticalsBoard seat
via Iaso Ventures · filed May 2026 · $1.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Iaso Ventures
Anil S. Jina
Executive in Residence at Iaso Ventures
Chandra Ramanathan
Advisor, Biotech at Iaso Ventures
John Reynders
Chief Data Scientist & Venture Partner at Iaso Ventures
Maurizio Fava
Advisor, Clinical R&D at Iaso Ventures
Michael Fenn
Venture Partner at Iaso Ventures
Noah J. Richmond
Advisor, Legal & IP at Iaso Ventures
Sadiqa Mahmood
Entrepreneur in Residence at Iaso Ventures
Sharon Tan
Executive in Residence at Iaso Ventures
Frequently asked questions
- Who is Mark G. Currie?
- Biopharma leader and pharmacologist, former President and CSO and scientific founder of Cyclerion Therapeutics and R&D leader at Ironwood. Primary inventor of linaclotide (Linzess), with numerous board and advisory roles.
- Where does Mark G. Currie work?
- Mark G. Currie is Venture Partner at Iaso Ventures and Board director at Sea Pharmaceuticals.
- What boards does Mark G. Currie sit on?
- Mark G. Currie holds tracked board seats at Sea Pharmaceuticals.
- Where did Mark G. Currie go to school?
- Mark G. Currie studied at Wake Forest University School of Medicine (Doctor of Philosophy - PhD, Cell Biology and Anatomy); University of South Alabama (Bachelor of Science - BS, Biology); University of South Alabama (Bachelor of Science - BS, Cell/Cellular Biology and Histology).
